Reply to Classification of biliary tract cancer (BTC): evaluation of all entities

Giorgia Randi; Matteo Malvezzi; Fabio Levi; Jacques Ferlay; Eva Negri; Silvia Franceschi; Carlo La Vecchia

doi:10.1093/annonc/mdp276

Related publications

Article2018

M7824 (MSB0011359C), a bifunctional fusion protein targeting transforming growth factor β (TGF-β) and PD-L1, in Asian patients with pretreated biliary tract cancer (BTC): Efficacy by BTC subtype

Changhoon Yoo, Do‐Youn Oh, Hye Jin Choi, Masatoshi Kudo, Makoto Ueno, Shunsuke Kondo, L.-T. Chen, Mitsumasa Osada, Christoph Helwig, Isabelle Dussault, Masafumi Ikeda

Article2015

Medical Conditions, Family History of Cancer, and the Risk of Biliary Tract Cancers

Valentina Rosato, Cristina Bosetti, Luigino Dal Maso, Maurizio Montella, Diego Serraino, Eva Negri, Carlo La Vecchia

Article2008

Epidemiology of biliary tract cancers: an update

Giorgia Randi, Matteo Malvezzi, Fabio Levi, Jacques Ferlay, Eva Negri, Silvia Franceschi, Carlo La Vecchia

Article2021

Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma

Juliette Paillet, Céleste Plantureux, Sarah Lévesque, Julie Le Naour, Gautier Stoll, Allan Sauvat, Pamela Caudana, Jimena Tosello, Norma Bloy, Sylvie Lachkar, Isabelle Martins, Paule Opolon, Andrea Checcoli, Agathe Delaune, Noémie Robil, Pierre de la Grange, Juliette Hamroune, Franck Letourneur, Gwennhaël Autret, Patrick S.C. Leung, M. Eric Gershwin, Jie Zhu, Mark J. Kurth, Bouchra Lekbaby, Jérémy Augustin,

Letter2014

Reply to Colorectal cancer classification based on gene expression is not associated with FOLFIRI response

Anguraj Sadanandam, Joe W. Gray, Douglas Hanahan